Senior insider sale
Chief People Officer at CENTESSA PHARMACEUTICALS PLC — senior position signals high conviction
$982.1K
53.93K shares
What this filing means
ANDERSON KAREN M. plans to sell 53.93K shares of CENTESSA PHARMACEUTICALS PLC valued at approximately $982.1K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/10/2025ACC: 0001973141-25-000076
Officer· Chief People Officer
Since Mar 2026
53.93K
Shares to sell
$982.1K
Approx. market value
429.00
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months1
Exercise of Stock Options
CASH
2/10/2025
429.00Total acquired429.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/10/2025 | Exercise of Stock Options CASH | 429.00 | — |
| Total | 429.00 | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
30.53K
Market value
$580.8K
2/7/2025
—Completed
Units to sell
6.47K
Market value
$109.1K
2/3/2025
—Completed
Units to sell
10.62K
Market value
$184.0K
12/17/2024
—Completed
Units to sell
5.88K
Market value
$100.0K
12/13/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
429.00
Market value
$8.1K
2/10/2025
Total
Units
53.93K
Value
$982.1K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
2/7/2025 | 30.53K | $580.8K | — | Completed |
2/3/2025 | 6.47K | $109.1K | — | Completed |
12/17/2024 | 10.62K | $184.0K | — | Completed |
12/13/2024 | 5.88K | $100.0K | — | Completed |
| Planned — Approximate Date | ||||
2/10/2025 | 429.00 | $8.1K | Nasdaq | Planned |
| Total | 53.93K | $982.1K | ||